{"id":"clm_2EBAE376F4A3","entity":"vertex-pharmaceuticals","predicate":"cash_and_equivalents","value":"8,702,200,000 United States dollar","value_json":{"fp":"Q2","fy":2022,"accn":"0000875320-22-000030","form":"10-Q","filed":"2022-08-05","period":"Q2 FY2022","concept":"us-gaap:CashAndCashEquivalentsAtCarryingValue"},"valid_from":"2022-06-30","valid_to":"2022-09-30","published":"2022-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Vertex Pharmaceuticals cash and equivalents: 8,702,200,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_2EBAE376F4A3, https://asof.is/claim/clm_2EBAE376F4A3, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532022000030/0000875320-22-000030-index.htm.","url":"https://asof.is/claim/clm_2EBAE376F4A3","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_0BD6127815F8","supersedes":["clm_AAF7A5074870"],"first_seen_at":"2026-11-08T17:02:27.400953+00:00","updated_at":"2026-11-08T17:02:34.884621+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532022000030/0000875320-22-000030-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2022","published_at":"2022-08-05T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2022, filed 2022-08-05"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}